查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球等溫線核酸擴增技術市場 - 2023-2030年
市場調查報告書
商品編碼
1297824

全球等溫線核酸擴增技術市場 - 2023-2030年

Global Isothermal Nucleic Acid Amplification Technology Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

全球等溫核酸擴增技術市場在2022年達到33億美元，預計到2030年將見證有利的成長，達到75億美元。預計在2023-2030年預測期內，等溫核酸擴增技術市場將呈現11.1%的複合成長率。

等溫核酸擴增是一種在穩定的溫度下快速有效地收集核酸系列的技術。核酸擴增技術在分子生物學和重組DNA方法中被採用。這些方法被作為識別和調查少量核酸的頂級做法。

市場動態

全球範圍內傳染病發病率的成長推動了預測期內全球等溫核酸擴增技術市場的發展。

全球範圍內傳染病發病率的不斷成長，正在推動預測期內全球等溫核酸擴增技術（INAAT）市場的成長。例如，世界衛生組織在2022年10月24日至11月23日期間登記了超過5000名新鮮猴痘患者。此外，在2021年底，超過1170萬人接受抗逆轉錄病毒治療（ART）的結果，CDC通過美國總統的艾滋病應急計劃對艾滋病毒護理和治療的援助。

不斷成長的老年人口為全球等溫核酸擴增技術市場提供了前景廣闊的成長機會。

不斷成長的老年人口為全球等溫核酸擴增市場提供了未來幾年的成長機會。例如，根據聯合國發布的《2022年世界人口前景》，80歲或以上的人的數量預計將成長三倍，從2022年的1.57億成長到2050年的4.59億。

COVID-19影響分析

COVID-19分析包括COVID前情景、COVID情景和COVID後情景，以及定價動態（包括大流行期間和之後的定價變化與COVID前情景的比較）、需求-供應譜（由於貿易限制、封鎖和後續問題造成的需求和供應轉移）、政府計劃（政府機構為振興市場、部門或行業而採取的計劃）和製造商戰略計劃（這裡將涵蓋製造商為緩解COVID問題所採取的措施）。

俄烏戰爭影響分析

這場戰爭對全球等溫線核酸擴增市場產生了輕微的負面影響，因為自俄羅斯的攻擊開始以來，世界衛生組織已經記錄了703起對衛生基礎設施的攻擊。此外，隨著俄羅斯武裝部隊深入鄰國烏克蘭的心臟地帶，鋁、銅、鋼和塑膠等關鍵原料的成本，與一般通貨膨脹分開，目前正威脅著白色商品的額外成本升級。然而，儘管發生了戰爭，烏克蘭繼續為病人提供必要的醫療服務。

全球經濟衰退影響分析

醫療保健行業並非完全不受經濟衰退的影響，因為醫療保健機構在過去的金融衰退中認為有解僱和就業。儘管如此，由於其基本性質，該行業確實比其他行業應對得更好。然而，隨著通貨膨脹的持續增加，衰退的危險威脅著市場。

由於全球已開發國家的高通貨膨脹率，對持續衰退的緊張程度上升，在過去兩年中出現了普遍的成本激增。累積惡化的一般購買控制預計將特別影響成長中的經濟體，並被認為在許多方面有幫助。

人工智慧影響分析

人工智慧估計會在未來幾年內對全球等溫核酸擴增市場產生積極影響。人工智慧（AI）和物聯網（IoT）技術（AIoT）的結合可能是自兩個世紀前第一台商業製冰機發明以來對等溫核酸擴增的最大破壞。

目錄

第一章：方法和範圍

  • 研究方法
  • 報告的研究目標和範圍

第二章：定義和概述

第三章：執行摘要

  • 按產品類型分類的摘要
  • 按應用分類的摘要
  • 按技術分類
  • 按終端用戶分類

第四章：動態變化

  • 影響因素
    • 驅動因素
      • 用於儲存目的的等溫核酸擴增技術的需求上升。
      • 市場的發展。
    • 限制因素
      • 使用翻新設備的趨勢日益明顯
    • 機會
    • 政府計劃
    • 影響分析

第五章：行業分析

  • 波特的五力分析
  • 監管分析
  • 價格分析
  • 專利分析
  • PEST分析

第六章：COVID-19分析

  • COVID-19的分析
    • COVID-19之前的情況
    • COVID-19之後的情況
    • COVID-19之後的情況
  • 在COVID-19中的定價動態
  • 需求-供應譜系
  • 大流行期間與市場有關的政府計劃
  • 製造商的戰略計劃
  • 結語

第7章：俄羅斯-烏克蘭戰爭分析

第八章：全球經濟衰退分析

第九章：人工智慧影響分析

第十章：按產品類型

  • 儀器
  • 試劑

第十一章：按應用分類

  • 傳染性疾病的診斷
  • 血液篩查
  • 癌症研究
  • 其他應用

第十二章：按技術分類

  • 基於核酸序列的擴增技術（NASBA）。
  • 單引物等溫擴增(SPIA)
  • 尼克酶擴增反應(NEAR)
  • 依賴螺旋酶的擴增(HDA)
  • 轉錄介導的擴增(TMA)
  • 環路介導的等溫擴增（LAMP）。
  • 鍊式置換擴增（SDA）
  • 其他

第十三章：按終端用戶

  • 醫院和診所
  • 診斷中心
  • 研究實驗室
  • 其他

第十四章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 亞太其他地區
  • 中東和非洲

第15章：競爭格局

  • 競爭格局
  • 市場佔有率分析
  • 合併和收購分析

第十六章：公司簡介

  • Thermo Fisher Scientific Inc.
    • 公司概述
    • 產品類型組合和描述
    • 財務概況
    • 主要發展情況
  • bioMerieux
  • Becton, Dickinson & Company
  • Lucigen
  • Qiagen
  • Quidel Corporation
  • Eiken Chemical Co. Ltd
  • Tecan Genomics Inc.
  • Meridian Bioscience
  • OptiGene Limited

第十七章：附錄

簡介目錄
Product Code: CD2081

Market Overview

The Global Isothermal Nucleic Acid Amplification Technology Market reached USD 3.3 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 7.5 billion by 2030. the isothermal nucleic acid amplification technology market is expected to exhibit a CAGR of 11.1% during the forecast period 2023-2030.

Isothermal nucleic acid amplification is a technique that quickly and effectively collects nucleic acid series at a consistent temperature. Nucleic acid amplification technologies are employed in molecular biology and recombinant DNA approaches. These methods are employed as top practices in identifying and investigating a short number of nucleic acids.

Market Dynamics

The Growing Prevalence of Infectious Diseases Globally is Driving the Global Isothermal Nucleic Acid Amplification Technology Market in the Forecast Period.

The growing prevalence of infectious diseases globally is driving the global isothermal nucleic acid amplification technology (INAAT) market growth during the forecast period. For instance, the World Health Organization registered over 5,000 fresh monkeypox patients between October 24, 2022 to November 23, 2022. Moreover, at the end of 2021, over 11.7 million individuals were on Anti Retroviral Treatment (ART) outcome of the CDC's aid for HIV care and treatment via the U.S. President's Emergency Plan for AIDS Response.

The Growing Geriatric Population is Providing the Global Isothermal Nucleic Acid Amplification Technology Market With Prospective Growth Opportunities.

The growing geriatric population is presenting the global isothermal nucleic acid amplification market with prospective growth opportunities in the upcoming years. For instance, according to the World Population Prospects 2022, from the UN, the number of individuals aged 80 or above is anticipated to grow triple fold, from 157 million in 2022 to 459 million by 2050.

COVID-19 Impact Analysis

The COVID-19 analysis includes Pre-COVID Scenario, COVID Scenario, and Post-COVID Scenario along with Pricing Dynamics (Including pricing change during and post-pandemic comparing it to pre-COVID scenarios), Demand-Supply Spectrum (Shift in demand and supply owing to trading restrictions, lockdown and subsequent issues), Government Initiatives (Initiatives to revive market, sector or Industry by Government Bodies) and Manufacturers Strategic Initiatives (What manufacturers did to mitigate the COVID issues will be covered here).

Russia-Ukraine War Impact Analysis

The war has negatively impacted the global isothermal nucleic acid amplification market to a slight extent as the WHO has recorded 703 attacks on health infrastructure since Russia's attack started. Moreover, as Russian armed forces progress deeper into the heart of neighboring Ukraine, costs of key raw materials such as aluminum, copper, steel and plastic, separated from general inflation, are currently threatening additional cost escalation for white goods commodities. However, despite the War, Ukraine continues to provide necessary health services to patients.

Global Recession Impact Analysis

The healthcare industry is not completely immune to recession, as healthcare institutions thought firings and employment during past financial downturns. That stated, the industry does cope finer than other sectors because of its essential nature. However, the danger of recession threatens the market as inflation persists increasing.

The elevated extent of tension about the persistent recession as the high inflation in developed countries worldwide has transpired in a general cost surge over the past two years. The cumulatively deteriorating general purchasing control is anticipated to affect growing economies particularly and is considered helpful in numerous ways.

Artificial Intelligence Impact Analysis

Artificial intelligence is estimated to have a positive impact on the global isothermal nucleic acid amplification market in the upcoming years. The combination of artificial intelligence (AI) and Internet of Things (IoT) technology (AIoT) may be the biggest disruption to the isothermal nucleic acid amplification since the invention of the first commercial ice-making machine two centuries ago.

Segment Analysis

The global isothermal nucleic acid amplification technology market is segmented based on product type, applications, technology and region.

The Loop-mediated Isothermal Amplification (LAMP) Technology Type Segment is Expected to Hold a Dominant Position in the Market Over the Forecast Period.

Loop-mediated Isothermal Amplification (LAMP) is estimated to hold 28.6% of the market share by 2030 owing to the increasing product introductions into the market. For instance, in March 2022, Thermo fisher scientific, an American supplier of scientific instrumentation, reagents and consumables and software services, introduced two new reverse transcription loop-mediated isothermal amplification-based developments that deliver a rapid and inexpensive technique for identifying viral pathogens.

Geographical Analysis

Europe is Estimated to Hold the Second-largest Share of the Global Isothermal Nucleic Acid Amplification Technology Market During the Forecast Period.

Owing to the increasing number of cancer deaṭhs and growing efforts to fight against cancer Europe is estimated to hold around 25.9% of the global isothermal nucleic acid amplification market by 2030. For instance, according to the 2022 edition of Health at a Glance, cancer is the second greatest reason for death in the EU behind cardiovascular disorders.

Between 30-50% of cancer patients' deaths are avoidable and mortality can also be reduced through earlier detection and the condition of better punctual and effective therapies. Europe's Beating Cancer Plan strives to decrease the load of cancer and manage cancer-related imbalances between and within nations, with efforts to help, coordinate and complete the actions of Member States.

Competitive Landscape

The major global players in the market include: bioMerieux, Becton, Dickinson & Company, Lucigen, Qiagen, Quidel Corporation, Eiken Chemical Co. Ltd, Tecan Genomics Inc., Meridian Bioscience, OptiGene Limited and Thermo Fisher Scientific among others.

Why Purchase the Report?

  • To visualize the global isothermal nucleic acid amplification technology market segmentation based on product type, applications, technology, end user, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of isothermal nucleic acid amplification technology market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The Global Isothermal Nucleic Acid Amplification Technology Market Report Would Provide Approximately 53 Tables, 54 Figures and 195 pages.

Target Audience 2023

  • Manufacturers / Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Applications
  • 3.3. Snippet by Technology
  • 3.4. Snippet by End User

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Demand for Isothermal Nucleic Acid Amplification Technology for Storage Purposes
      • 4.1.1.2. Market Developments.
    • 4.1.2. Restraints
      • 4.1.2.1. The Growing Trend of Using Refurbished Equipment
    • 4.1.3. Opportunity
    • 4.1.4. Government Initiatives
    • 4.1.5. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Regulatory Analysis
  • 5.3. Pricing Analysis
  • 5.4. Patent Analysis
  • 5.5. PEST Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario After COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine War Analysis

8. Global Recession Analysis

9. Artificial Intelligence Impact Analysis

10. By Product Type

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.1.2. Market Attractiveness Index, By Product Type
  • 10.2. Instruments
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Reagents

11. By Applications

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
    • 11.1.2. Market Attractiveness Index, By Applications
  • 11.2. Infectious Diseases Diagnostics*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Blood Screening
  • 11.4. Cancer Research
  • 11.5. Others

12. By Technology

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 12.1.2. Market Attractiveness Index, By Technology
  • 12.2. Nucleic Acid Sequence-based Amplification (NASBA)
    • 12.2.1. Introduction
    • 12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 12.3. Single Primer Isothermal Amplification (SPIA)
  • 12.4. Nicking Enzyme Amplification Reaction (NEAR)
  • 12.5. Helicase-dependent Amplification (HDA)
  • 12.6. Transcription Mediated Amplification (TMA)
  • 12.7. Loop-mediated Isothermal Amplification (LAMP)
  • 12.8. Strand Displacement Amplification (SDA)
  • 12.9. Others

13. By End User

  • 13.1. Introduction
    • 13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 13.1.2. Market Attractiveness Index, By End User
  • 13.2. Hospitals and Clinics
    • 13.2.1. Introduction
    • 13.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 13.3. Diagnostic Center
  • 13.4. Research Laboratories
  • 13.5. Others

14. By Region

  • 14.1. Introduction
    • 14.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 14.1.2. Market Attractiveness Index, By Region
  • 14.2. North America
    • 14.2.1. Introduction
    • 14.2.2. Key Region-Specific Dynamics
    • 14.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 14.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
    • 14.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 14.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 14.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 14.2.7.1. The U.S.
      • 14.2.7.2. Canada
      • 14.2.7.3. Mexico
  • 14.3. Europe
    • 14.3.1. Introduction
    • 14.3.2. Key Region-Specific Dynamics
    • 14.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 14.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
    • 14.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 14.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 14.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 14.3.7.1. Germany
      • 14.3.7.2. The U.K.
      • 14.3.7.3. France
      • 14.3.7.4. Italy
      • 14.3.7.5. Spain
      • 14.3.7.6. Rest of Europe
  • 14.4. South America
    • 14.4.1. Introduction
    • 14.4.2. Key Region-Specific Dynamics
    • 14.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 14.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
    • 14.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 14.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 14.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 14.4.7.1. Brazil
      • 14.4.7.2. Argentina
      • 14.4.7.3. Rest of South America
  • 14.5. Asia-Pacific
    • 14.5.1. Introduction
    • 14.5.2. Key Region-Specific Dynamics
    • 14.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 14.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
    • 14.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 14.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 14.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 14.5.7.1. China
      • 14.5.7.2. India
      • 14.5.7.3. Japan
      • 14.5.7.4. Australia
      • 14.5.7.5. Rest of Asia-Pacific
  • 14.6. Middle East and Africa
    • 14.6.1. Introduction
    • 14.6.2. Key Region-Specific Dynamics
    • 14.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 14.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
    • 14.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 14.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

15. Competitive Landscape

  • 15.1. Competitive Scenario
  • 15.2. Market Share Analysis
  • 15.3. Mergers and Acquisitions Analysis

16. Company Profiles

  • 16.1. Thermo Fisher Scientific Inc.
    • 16.1.1. Company Overview
    • 16.1.2. Product Type Portfolio and Description
    • 16.1.3. Financial Overview
    • 16.1.4. Key Developments
  • 16.2. bioMerieux
  • 16.3. Becton, Dickinson & Company
  • 16.4. Lucigen
  • 16.5. Qiagen
  • 16.6. Quidel Corporation
  • 16.7. Eiken Chemical Co. Ltd
  • 16.8. Tecan Genomics Inc.
  • 16.9. Meridian Bioscience
  • 16.10. OptiGene Limited

LIST NOT EXHAUSTIVE

17. Appendix

  • 17.1. About Us and Services
  • 17.2. Contact Us